This study sought to investigate the association of stroke aetiology, LAA vs. CE, with pre-intervention collateral status (good vs. poor) in AIS patients receiving reperfusion therapy (RT), specifically systemic thrombolysis (using tissue plasminogen activator (tPA)) and/or endovascular thrombectomy (EVT), by performing a meta-analysis. The gene discussed is PLAT; the disease is Stroke.